PCI in High Bleeding Risk Patients: What is “Optimal” Therapy?



Mitchell Krucoff
Professor Medicine/Cardiology, Duke University Medical Center Director, Cardiovascular Devices Unit Director, eECG Core Laboratories Duke Clinical Research Institute-, USA, USA
העלאת קובץ המאמר או המצגת

Mitchell Krucoff